We could trigger weight loss signals that happen later in the pathway more directly. A new company called CoronationBio has been launched to turn this discovery into a real-world treatment
An example patient journey is below
[DOI] [PubMed] [Google Scholar] Bode-Boger SM, Boger RH, Galland A, Tsikas D, Frolich J
This hydrophobic appendage promotes non-covalent, high-affinity binding to circulating albumin, effectively turning the plasma protein into a reversible depot and raising the terminal half-life to roughly one week, compatible with once-weekly (OW) dosing in humans, which enhances accessibility compared to daily regimens [38]
Primary end points: increase in soluble leptin receptor plasma levels and decrease in free leptin index after 52 weeks weight loss maintenance
This is the blueprint for safe, effective, long-term peptide therapy .